Crossmark

Clinical efficacy and bleeding outcomes of tissue plasminogen activator and dornase alfa in pleural space infection with once daily concurrent administration: a retrospective cohort study

Crossref DOI link: https://doi.org/10.1186/s13104-020-05210-2

Published Online: 2020-08-03

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jiang, Chuan http://orcid.org/0000-0002-1601-6854
Xie, Meng

Cervellione, Kelly

Thurm, Craig
License Information

Text and Data Mining valid from 2020-08-03

Version of Record valid from 2020-08-03
More Information

Article History

Received: 15 June 2020

Accepted: 28 July 2020

First Online: 3 August 2020

Ethics approval and consent to participate

: The study was approved by the Jamaica Hospital Medical Center Institutional Review Board (IRB# 1527223). Our medical center is located within the United States of America.

: Not applicable.

: All authors report no financial disclosures or ethical conflicts of interest regarding this study.

Document is current

Any future updates will be listed below